Pablo Avilés
Impact in
- Biotechnology top 5%
- Marine Sponges and Natural Products
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 5
- Lung Cancer Research Studies 5
-
- Cancer therapeutics and mechanisms 14
- Co-authors
- Carlos M. Galmarini (19 shared papers)Juan Fernando Martínez-Leal (7 shared papers)Carmen Cuevas (26 shared papers)María José Guillén (27 shared papers)Carlos Mario Genes Robles (1 shared paper)Jean‐Marc Egly (1 shared paper)Emmanuel Compe (1 shared paper)Gema Santamaría Núñez (2 shared papers)
- Journals
- Cancer Research (13 papers)Journal of Pharmaceutical and Biomedical Analysis (4 papers)Molecular Cancer Therapeutics (4 papers)Biochemical Pharmacology (4 papers)Rapid Communications in Mass Spectrometry (3 papers)
- Partner nations
- SpainBelgiumNetherlands
In The Last Decade
Pablo Avilés
65 papers receiving 869 citations
Peers
Comparison fields: 5 of 97
- Biotechnology 131
- Oncology 282
- Cancer Research 154
- Toxicology 26
- Pharmacology 126
Countries citing papers authored by Pablo Avilés
This map shows the geographic impact of Pablo Avilés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Avilés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Avilés more than expected).
Fields of papers citing papers by Pablo Avilés
This network shows the impact of papers produced by Pablo Avilés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Avilés. The network helps show where Pablo Avilés may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Avilés, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 114 | |
| 2 | 2008 | 73 | |
| 3 | 2016 | 68 | |
| 4 | 2009 | 54 | |
| 5 | 2014 | 46 | |
| 6 | 1995 | 42 | |
| 7 | 2013 | 29 | |
| 8 | 2019 | 28 | |
| 9 | 2015 | 28 | |
| 10 | 2018 | 27 | |
| 11 | 2016 | 26 | |
| 12 | 2013 | 20 | |
| 13 | 2020 | 19 | |
| 14 | 2021 | 18 | |
| 15 | 2009 | 18 | |
| 16 | 2022 | 18 | |
| 17 | 2018 | 16 | |
| 18 | 2011 | 15 | |
| 19 | 2020 | 14 | |
| 20 | 2017 | 14 |
About Pablo Avilés
Pablo Avilés is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Organic Chemistry, having authored 72 papers that have together received 888 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), Cancer Treatment and Pharmacology (10 papers), Synthesis and Biological Activity (8 papers), HER2/EGFR in Cancer Research (5 papers), Microtubule and mitosis dynamics (5 papers), Multiple Myeloma Research and Treatments (5 papers), Radiation Detection and Scintillator Technologies (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Biotechnology (131 citations), Oncology (282 citations), Cancer Research (154 citations), Toxicology (26 citations) and Pharmacology (126 citations). Pablo Avilés has collaborated with scholars based in Spain, Belgium and Netherlands. Frequent co-authors include Carlos M. Galmarini, Juan Fernando Martínez-Leal, Carmen Cuevas, María José Guillén, Carlos Mario Genes Robles, Jean‐Marc Egly, Emmanuel Compe, Gema Santamaría Núñez, Frédéric Coin and Pilar Calvo. Their work appears in journals such as Cancer Research, Journal of Pharmaceutical and Biomedical Analysis, Molecular Cancer Therapeutics, Biochemical Pharmacology and Rapid Communications in Mass Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.